Management of Blocked Femoral Dialysis Catheter
For a blocked femoral dialysis catheter, initiate thrombolytic therapy with intraluminal urokinase or tPA lock (5,000 U/mL urokinase or 1-4 mg/lumen tPA) for 30 minutes to several hours, and if this fails after 2 consecutive treatments, proceed to radiological evaluation for guidewire exchange or catheter replacement. 1, 2
Initial Management Algorithm
Step 1: Bedside Thrombolytic Lock Therapy
When blood flow drops below 300 mL/min for 2 consecutive dialysis treatments, begin with intraluminal thrombolytic therapy 2:
NKF-K/DOQI Protocol:
- Attempt to aspirate the occluded lumen to remove heparin
- Inject urokinase 5,000 U/mL (1 mL or volume sufficient to fill lumen) using a 3 mL syringe
- Fill remainder of catheter lumen with saline if needed
- Add 0.3 mL saline every 10 minutes to move active urokinase to distal catheter
- Aspirate catheter after 30 minutes
- Repeat if necessary 1
Alternative tPA Protocol:
- Infuse 1-4 mg/lumen over 1-4 hours, which typically restores flow >200 mL/min sufficient for dialysis completion 2
- tPA infusion may succeed when simple dwell technique fails because more lytic reaches the thrombus/fibrin 2
Step 2: Radiological Evaluation (If Bedside Therapy Fails)
Any dysfunction not resolved in the dialysis unit requires fluoroscopic evaluation 2:
Contrast catheter imaging can identify:
- Residual lumen thrombus
- External fibrin sheath
- Malpositioned catheter tip
- Vessel stenosis 2
Interventional options based on findings:
- Catheter repositioning if malpositioned
- Guidewire exchange with balloon disruption of fibrin sheath (preferred approach) 2
- Higher-dose lytic infusion for occlusive thrombus or fibrin sheath
- Angioplasty of stenotic vessel 2
Critical Considerations for Femoral Catheters
Infection Assessment
Before any intervention, exclude infection 1:
- Exit site infection, tunnel infection, or systemic infection requires catheter removal, not salvage attempts
- Non-cuffed femoral catheters should be removed if any infection is present 1
Femoral Catheter-Specific Limitations
Femoral catheters have inherent disadvantages that affect management decisions 1, 3, 4:
- Should not remain in place >5 days for non-cuffed catheters 1
- Primary patency substantially shorter than internal jugular catheters (median 59 vs >300 days) 3
- Higher infection rates compared to thoracic sites 1
- 26% risk of ipsilateral deep vein thrombosis (though catheter use can continue with anticoagulation) 3
- Must be ≥19 cm long to reach inferior vena cava and minimize recirculation 1
When to Replace Rather Than Salvage
Replace the catheter if:
- Thrombolytic therapy fails after repeated attempts
- Exit site or tunnel infection is present
- Catheter has been in place >5 days (for non-cuffed) 1
- Radiological evaluation shows irreparable mechanical problems
- Patient requires ongoing dialysis and femoral site is only temporary option
Guidewire exchange is preferred over new site placement when 1:
- Exit site and tunnel are not infected
- Vessel remains patent on imaging
- Allows fibrin sheath disruption with balloon during exchange 2
Alternative Access Planning
Given femoral catheters' poor long-term outcomes, simultaneously plan for definitive access 5:
- Femoral catheters are last-resort when upper extremity options exhausted
- Preserve iliac vessels if transplant anticipated
- Consider tunneled cuffed catheter in opposite extremity if AV access creation planned 5
- Evaluate for upper extremity AV fistula or graft creation while femoral catheter provides temporary access
Common Pitfalls to Avoid
- Do not use antibiotics alone for catheter-related bloodstream infection—this fails in majority of cases 6
- Do not leave non-cuffed femoral catheters >5 days—infection and dislodgment rates become unacceptable 1
- Do not attempt salvage if any signs of infection—remove catheter immediately 1
- Do not use simple dwell technique exclusively—infusion protocols are more effective for resistant occlusions 2
- Do not ignore recirculation rates—femoral catheters recirculate significantly more than thoracic catheters, compromising dialysis adequacy 7
The evidence strongly supports aggressive initial thrombolytic therapy, but femoral catheters should be viewed as temporary bridges requiring prompt transition to more durable access options given their substantially inferior patency and higher complication rates compared to internal jugular catheters.